Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nephros | NEPH | 14. nov 2024 | 1.58 | -3.07 |
NerdWallet A | NRDS | 14. nov 2024 | 14.56 | -4.96 |
Nerdy A | NRDY | 14. nov 2024 | 0.84 | +2.59 |
Net Lease Office Properties When Issued | NLOP | 14. nov 2024 | 31.12 | -0.95 |
Net Power A | NPWR | 14. nov 2024 | 13.10 | +2.02 |
NetApp | NTAP | 14. nov 2024 | 118.07 | -1.35 |
Netcapital | NCPL | 14. nov 2024 | 1.76 | +2.33 |
NetEase ADR | NTES | 14. nov 2024 | 84.22 | +10.41 |
Netflix | NFLX | 14. nov 2024 | 837.26 | +0.82 |
NETGEAR | NTGR | 14. nov 2024 | 24.15 | +1.56 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | 14. nov 2024 | 45.18 | +0.78 |
NetScout Systems | NTCT | 14. nov 2024 | 22.42 | -1.45 |
NETSOL Technologies | NTWK | 14. nov 2024 | 2.87 | -1.71 |
Netstreit | NTST | 14. nov 2024 | 15.46 | -1.40 |
Network-1 Technologies | NTIP | 14. nov 2024 | 1.35 | +2.27 |
Neuberger Berman | NML | 14. nov 2024 | 8.97 | -0.44 |
Neuberger Berman High Yield Strategies Fund | NHS | 14. nov 2024 | 7.93 | 0.00 |
Neuberger Berman Municipal Fund | NBH | 14. nov 2024 | 10.69 | +0.09 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | 14. nov 2024 | 13.22 | +0.30 |
Neuberger Berman Real Estate Securities Income Fund | NRO | 14. nov 2024 | 3.81 | 0.00 |
NeueHealth | NEUE | 14. nov 2024 | 5.07 | +8.80 |
Neumora Therapeutics | NMRA | 14. nov 2024 | 11.69 | +8.49 |
Neuraxis | NRXS | 14. nov 2024 | 3.27 | +3.48 |
Neurobo Pharmaceuticals | NRBO | 14. nov 2024 | 2.39 | -6.64 |
Neurocrine Biosciences | NBIX | 14. nov 2024 | 122.88 | -2.10 |
Neurogene | NGNE | 14. nov 2024 | 39.20 | -1.16 |
NeuroMetrix | NURO | 14. nov 2024 | 3.79 | +5.57 |
Neuronetics | STIM | 14. nov 2024 | 0.79 | +29.59 |
NeuroOne | NMTC | 14. nov 2024 | 0.78 | -9.71 |
Neuropace | NPCE | 14. nov 2024 | 9.68 | +5.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.